Prostate Cancer | Topics

Platinum-Based Treatment Associated with Antitumor Activity in Some Patients with Advanced Prostate Cancer
November 22, 2020

Researchers suggested that platinum-based treatment may be considered an option in a biomarker-positive population of patients with advanced prostate cancer with DNA repair gene aberrations.

FDA Approves FoundationOne Liquid CDx as Companion Diagnostic for Olaparib
November 09, 2020

The FDA has approved the FoundationOne Liquid CDx to identify patients with BRCA1, BRCA2, and/or ATM alterations in patients with metastatic castration-resistant prostate cancer who may be appropriate for treatment with olaparib.

Recap: CancerNetwork® Tweet Chat on Prostate Cancer
November 05, 2020

In a mock tumor board on prostate cancer on Twitter, health care providers came together to discuss real patient cases and present various treatment options for review.